Let’s Know about SNP Genotyping and Analysis

Genotyping Market Information by Technology (Sequencing, Capillary Electrophoresis, PCR, and Others), Product (Reagents and Kits and Others), Application (Diagnostics and Others), End-User (Hospitals, Diagnostic Centers), and Region-Global Forecast till 2023Increasing burden of genetic disorders has raised awareness and encouraged investments for effective treatments.

This, in turn, is likely to enable genotyping in gaining quick mileage over the next few years.

According to the report circulated by Market Research Future (MRFR), the Global Genotyping Assay Market is projected to register a CAGR of 22.5% during the assessment period 2018 to 2023.Human genotyping is gaining momentum owing to the rising burden of genetic disorders.

However, the lack of skilled personnel can pose a challenge to players of the genotyping market.Genotyping Market Competitive Dashboard:QIAGEN, Illumina, Inc, Affymetrix, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., General Electric Company, Fluidigm Corporation, F. Hoffmann-La Roche Ltd, Sequenom, and Beckman Coulter, Inc. are some of the leaders in the global genotyping market profiled in this MRFR report.

The growth trajectory of the genotyping market is likely to attract new entrants, thus, facilitating expansion and revenue generation.

Strategies developed by the participants of the genotyping market for growth are mergers & acquisitions, collaborations, agreements, memorandum of understanding, increasing research activities, etc.Genotyping Market Segmentation:Based on technology, the global genotyping market has been segmented into sequencing, PCR, microarray, capillary electrophoresis, and mass spectrometry.

What This Report Will Provide?Genotyping platforms have several potential application areas such as pharmacogenomics, diagnostic research, personalized medicine, and forensics.

Furthermore, this technology is also apt for a range of veterinary needs, food safety and quality, and environmental testing in remote areas and industrial settings.

At present, human diagnostics and pharmacogenomics offer significant marker potential as these segments require rapid genotyping analysis on a large scale due to the need for better treatment options and high disease prevalence.Expected Revenue Growth:MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 22.0% during the forecast period.Major Growth Boosters:The major factors that are expected to be driving the genotyping assay market are technological advancements and the decreasing prices of DNA sequencing.

The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance of genotyping in drug development, and the increasing demand for bioinformatics solutions in data analysis are also expected to promote market growth in the coming years.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595The sequencing segment is expected to witness a faster growth rate in this market due to factors such as, the increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, and the growing uptake of the hybrid approach of sequencing.Critical questions the report answers:1.

Where will all these developments take the industry in the long term?2.

What are the upcoming trends for the genotyping market?3.

 According to the new market research report “Genotyping Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023", published by MarketsandMarkets™, The genotyping assay market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%.The growth of this market is mainly driven by technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595The reagents & kits segment is expected to grow at the highest CAGR during the forecast periodBased on product, the reagents and kits are expected to grow at the highest rate during the forecast period.

This segment is expected to witness the highest CAGR due to the easy accessibility of a wide range of reagents and the increasing need for genotyping in various applications.+ Based on product, the market is divided into reagents & kits, genotyping services, instruments, and bioinformatics.

The easy accessibility to a wide range of reagents and need for genotyping in various applications (such as assessing drug efficacy & safety, cutting down cost and time required for clinical development, personalizing the treatments for chronic diseases, and developing good breeds of animals and plants) have contributed to the high and repetitive consumption of reagents and kits as consumables in various genotyping applications.+ Based on technology, the genotyping assay market is segmented into PCR, microarrays, sequencing, capillary electrophoresis, MALDI-TOF, and other technologies.

The sequencing segment is expected to account for the largest share of the global genotyping market during the forecast period of 2018 to 2023.Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595Key Players and Strategies Adopted by Them:The genotyping market in the APAC is expected to grow at the highest CAGR during the forecast period.

This is due to the increasing incidence of chronic diseases, and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases and the spread of infectious and microbial diseases in APAC countries.

Global pharmaceutical and biopharmaceutical companies are also increasingly outsourcing clinical research and trials to companies in this region, which has increased the demand for genotyping products for drug profile assessment, drug efficacy and safety assessment, dosing determination, and drug response evaluation

03 Oct 2018 – Global Genotyping Market is expected to reach USD 37.1 billion by 2024. The Genotyping Market is estimated to grow at a significant CAGR over the forecast period as the scope and its applications are rising enormously across the globe.

Growing availability of several types of products, decreasing cost of DNA sequencing, rising awareness and occurrence of genetic diseases, increasing use of plant and animal livestock for genetic analysis, and growing demand for pharmacogenomics in drug discovery & development are documented as major factors of Genotyping Market that are estimated to enhance the growth in the years to come.

Global Genotyping Market is expected to reach USD 37.1 billion by 2024.

Genotyping is termed as a technology that detects small genetic differences, which may lead to a major change in phenotype.

However, lack of trained personnel’s may restrain overall market growth in the coming years.

Reagents and kits sector is estimated to grow at highest CAGR in the coming years.MALDI-TOF, Microarrays, Polymerase Chain Reaction (PCR), Capillary Electrophoresis, Sequencing, and other technologies may be explored in Genotyping in the forecast period.

Capillary Electrophoresis sector comprises Single Strand Conformation Polymorphism (SSCP), Restriction Fragment Length Polymorphism (RFLP), and Amplified Fragment Length Polymorphisms (AFLP).

On the other hand, sequencing sector includes Pyrosequencing, Next-generation Sequencing (NGS), and Sanger Sequencing.